PPBT

Purple Biotech
PPBT

8 hedge funds and large institutions have $390K invested in Purple Biotech in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$51.1K
2
+$26.3K
3
+$24.4K
4
UBS Group
UBS Group
Switzerland
+$14.3K
5
PVH
Psagot Value Holdings
Israel
+$478

Top Sellers

1
-$136K
2
-$57K
3
-$24K
4
MC
Menta Capital
California
-$17.7K
5
MIFH
Migdal Insurance & Financial Holdings
Israel
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$145K
2
$108K
3
$41K
4
$39K
5
$21K
6
$20K
7
$15K
8
$1K
9
–
10
–
11
–